Danaher (DHR) PT Lowered to $220 at Morgan Stanley
Tweet
Share
E-mailGet Alerts DHR Hot Sheet
Price: $211.81 -0.32%
Rating Summary:
30 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
30 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst Kallum Titchmarsh lowered the price target on Danaher (NYSE: DHR) to $220.00 (from $255.00) while maintaining a Overweight rating.
You May Also Be Interested In
- IDT and Aldevron launch Cas9 mRNA for CRISPR gene editing research
- Envista Holdings Corp. (NVST) PT Lowered to $27 at UBS, Neutral Rating Maintained
- Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
